why choose us

First received: January 14, 2023

Clinical Trial: Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

Study Status: Completed

Recruit Status: Completed

Condition: Anemia of Chronic Kidney Disease
Chronic Renal Failure
Chronic Renal Failure Anemia

Study Type: Observational


Official Title: Short Versus Long-Acting Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients

Brief Summary: This observational study aims to compare long-acting darbepoetin alpha versus short-acting epoetin alpha erythropoietin-stimulating agents in Egyptian hemodialysis patients. The main questions aim to answer are:What are the effectiveness and safety of long- acting versus short-acting erythropoietin-stimulating agents in Egyptian hemodialysis patients?What is the cost-effectiveness of long- acting versus short-acting erythropoietin-stimulating agents in Egyptian hemodialysis patients?Participants will be divided…

Read more